Home Newsfeeds Putin Says There Can Be No Winners In Nuclear War, It Should Never Be Started

Putin Says There Can Be No Winners In Nuclear War, It Should Never Be Started

-Reuters

byBenzinga Newsdesk

August 1, 2022

1 minute read

-Reuters

Parker Hannifin Raises FY23 Adj. EPS Outlook $20.60 – $2.90 Vs. $19.68 Estimate, GAAP EPS Outlook $14.75 – $15.05

By Benzinga Newsdesk

May 4, 7:35 AM

Parker has increased its outlook for organic sales and earnings per share for the fiscal year ending June 30, 2023. The company expects fiscal 2023 organic sales growth to be approximately 10% and earnings per share in

Benzinga Buzz: Jack Nicholson, Hollywood & The Big Whamola. Plus, The Nanny Rips Iger A New One.

By Anthony Noto

July 15, 11:16 AM

Each week, Benzinga Buzz compiles the latest entertainment news into a cohesive column for your consideration. Read on for the latest updates — both useful and irreverent.

COTY

Flora Growth Corp. Appoints Clifford Starke As Chief Executive Officer And Dany Vaiman As Chief Financial Officer; Regains Compliance With NASDAQ Minimum Bid Requirement

By Happy Mohamed

June 27, 4:08 PM

Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical

FLGC

Janssen Presents Efficacy And Subgroup Analyses From MAIA Study Showing Long-Term Results Of DARZALEX (daratumumab)-based Regimen In Newly Diagnosed, Transplant-Ineligible Multiple Myeloma

By Benzinga Newsdesk

December 12, 11:29 AM

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating

JNJ

Putin Says There Can Be No Winners In Nuclear War, It Should Never Be Started

Related Posts

Parker Hannifin Raises FY23 Adj. EPS Outlook $20.60 – $2.90 Vs. $19.68 Estimate, GAAP EPS Outlook $14.75 – $15.05

Benzinga Buzz: Jack Nicholson, Hollywood & The Big Whamola. Plus, The Nanny Rips Iger A New One.

Flora Growth Corp. Appoints Clifford Starke As Chief Executive Officer And Dany Vaiman As Chief Financial Officer; Regains Compliance With NASDAQ Minimum Bid Requirement

Janssen Presents Efficacy And Subgroup Analyses From MAIA Study Showing Long-Term Results Of DARZALEX (daratumumab)-based Regimen In Newly Diagnosed, Transplant-Ineligible Multiple Myeloma